FEATURED

New Gene Test for Bladder Cancer

Early research indicates the possibility for a urine test for bladder cancer.

Drug Showcase: CYRAMZA (ramucirumab)

Indicated for metastatic colorectal cancer.

The Spread of Metastatic Prostate Cancer

New research indicates that prostate cancer metastasis may spread from multiple tumor clones.

Patient-Reported Outcomes in Oncology Product Labeling

FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.

Treating Stage 1/2 Bulky Hodgkin Lymphoma

ABVD and Stanford V treatment regimens show similar efficacy in patients with Hodgkin lymphoma.

Bipolar Androgen Therapy in CRPC

Bipolar androgen therapy may benefit some men with asymptomatic CRPC who have a low to moderate metastatic burden.

Alternate Sunitinib Schedules for RCC

Understanding optimal dosing regimens for RCC could lead to improvements in the ability to refine dosing and scheduling for all oral anticancer therapies.

Ascites in Patients with Cancer

Up to 10 percent of ascites diagnoses are related to cancer.

Looking for a Job?

Access our job board to view over 1,​200 job openings throughout the US.

Treatment Regimens

A full listing of cancer treatment and drug information is available to access.

Viewpoints

New Genetic Sequencing May Lead to Urine Test for Bladder Cancer

New Genetic Sequencing May Lead to Urine Test for Bladder Cancer

Early research indicates the possibility for a urine test for bladder cancer.

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

Will Patient-Reported Outcomes Be Included in Oncology Product Labeling?

FDA, industry, and patients are talking, but agreement on how to include patient experiences in oncology product prescribing information remains elusive.

Feature Articles

Lethal Metastatic Prostate Cancer May Spread from Other Sites

Lethal Metastatic Prostate Cancer May Spread from Other Sites

New research indicates that prostate cancer metastasis may spread from multiple tumor clones.

ABVD, Radiotherapy vs. Stanford V in Stage 1/2 Bulky Hodgkin Lymphoma

ABVD, Radiotherapy vs. Stanford V in Stage 1/2 Bulky Hodgkin Lymphoma

ABVD and Stanford V treatment regimens show similar efficacy in patients with Hodgkin lymphoma.

Featured Videos

March/April Digital Issue

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs